CD83 and central nervous system cancer: EnrichR analysis of the identified DEGs (log2 fold change > 1; adjusted P value < 0.05) showed that most genes enriched in CD83+ tumor cells relate to neural and glioma cell pathways (Fig. 3B), indicating that expression of CD83 in tumor cells imparts biologically relevant changes to glioma cell transcriptomes.